For Afib patients, lowering the risk of stroke is crucial. A late-breaking trial presented at AHA Scientific Sessions compares anti-thrombotic agents when coronary disease is also a factor.
Medicare data show that tight connections among physicians have more to do with heart bypass surgery patients’ survival than other factors.
Hundreds of thousands of hospital patients get a pricey genetic test. But it’s often unnecessary, a team of U-M clinicians says.
When high-risk patients need surgery, doctors might take a cue from coaches. A U-M program is helping some clinicians draft the playbook.
In 20 years, only 92 gold-standard studies have been done for cardiac arrest, though it happens a staggering 535,000 times annually in the U.S.